Amerikaanse aandelen« Terug naar discussie overzicht

1. MyOpinion 19 augustus 2009 05:25

   auteur info

   •    MyOpinion

     Lid sinds: 22 jan 2005

     Laatste bezoek: 01 feb 2025

   •    Aanbevelingen

     Ontvangen: 220

     Gegeven: 167

   •    Aantal posts: 1.480

   IsoRay 120 % omhoog
   
   IsoRay, Inc. announced that it has received clearance from the FDA for its Premarket Notification, [510(k)] for Proxcelan Cesium-131 Brachytherapy Seeds enabling the Company to preload Cesium-131 into flexible braided strands and surgical mesh. This FDA clearance allows IsoRay to market Cesium-131 seeds for use in the treatment of cancers well beyond the current prostate market.
   
   www.isoray.com
2. [verwijderd] 19 augustus 2009 14:13

   auteur info

   •    [verwijderd]

     Lid sinds: 01 jan 0001

     Laatste bezoek: 01 jan 0001

   •    Aanbevelingen

     Ontvangen: 0

     Gegeven: 0

   •    Aantal posts: 0

   quote:

   postdufi40 schreef:

   Hey Skip,
   
   Misschien kun je ook eens je licht laten schijnen over:
   
   EKO.T (TSX)
   en
   GAP.V (TSX-Venture)
   
   Raymond
   
   

   Wijdt mij bijna niet op TSX markt,vindt al meer of genoeg op de usa markt of het moeten Canadese fondsen zijn die ook op de Nyse,Amex,Nasdaq, verhandelbaar zijn.
   
   Noveko International Inc. (EKO-T)
   Last: Change:
   2.580 -0.300 (-10.42%)
   Volume: 270,582 August 18, 2009
   
   cxa.marketwatch.com/tsx/en/market/quo...
   
   Dateert van 11 aug maar dit zult u zekers al weten.
   
   Press release from CNW Group
   NOVEKO INTERNATIONAL INC. announced the signature of a License and Supply Agreement with MICROBAN INTERNATIONAL, LTD.
   
   www.theglobeandmail.com/globe-investo...
   
   www.theglobeandmail.com/globe-investo...
   
   Tuesday, August 11, 2009
   
   Zie dat ze hier in 3 verschillende segmenten actief zijn waarvan dit hier me toch is opgevallen.Als ik het niet ben dan zijn het de landbouwers die nu hun licht kunnen doen schijnen bij aanschaf van zo'n echo apparaat waarvan ze dan de dracht van hun dieren op de voet kunnen volgen.
   
   Vingt cinq ans d'expérience en échographie vétérinaire, la mise en place de plus de 15.000 échographes ont permis à ECM de développer et de fabriquer en France une gamme d'échographes AGROSCAN, VSCAN et IMAGYNE répondant parfaitement aux besoins et contraintes des opérateurs.
   
   www.agroscan.com/AGROSCAN_WEB/FR/AGRO...
   
   ----------------------------------------------------
   PharmaGap
   
   * GAP
   * TSX Venture
   * Consumer Products
   
   
   * Latest 0.36
   * Currency C$
   * Change-0.02
   * Percent Change-5.19%
   * Volume790,450
   * Aug 18, 2009
   
   Return as of August 19 2009
   1 Month 160.00%
   6 Month 143.23%
   YTD 804.80%
   1 Year 208.45%
   
   Geen verse leugens hier of het moet dit hier zijn van 13.08.2009
   
   PharmaGap Advised By U.S. National Cancer Institute Of Positive Results Of Testing for the Company’s Lead Cancer Drug GAP-107B8
   
   Ottawa, Ontario/August 13, 2009 – PharmaGap Inc. (TSX-V: GAP; OTC.BB-PHRGF) (“PharmaGap” or “the Company”) has been advised by the U.S. National Cancer Institute (“NCI”) that the Company’s lead cancer drug GAP-107B8 (formerly known as PhG-alpha-1) has demonstrated sufficient anti-proliferative effect in the NCI’s initial single dose assay to warrant examination in an expanded “dose response” assay in which the compound will be evaluated against the NCI-60 cancer cell panel at five concentration levels. The NCI has further advised that the threshold for progression to the dose response assay is based on results in the single dose assay in comparison with historical data of compounds screened by the NCI that were of sufficient interest for review by the NCI’s DTP Biological Evaluation Committee. The NCI-60 protocol tests a wide variety of cancers, including breast, colorectal, lung, ovarian, kidney, prostate, leukemia and various central nervous system cancers and melanomas. A complete outline of the NCI’s compound screening process can be found at
   
   www.pharmagap.com/news/pr/08-13-2009....
   
   Ook verhandelbaar op de Otcb markt doch niet aan te raden gezien zeer lage volume gehalte.
   
   PHARMAGAP INC
   PHRGF
   Stock price
   0.3393 0.0069 2.08%
   
   finance.aol.com/quotes/pharmagap-inc/...
   
   Mvg,Skippy
   
   
3. [verwijderd] 20 augustus 2009 03:08

   auteur info

   •    [verwijderd]

     Lid sinds: 01 jan 0001

     Laatste bezoek: 01 jan 0001

   •    Aanbevelingen

     Ontvangen: 0

     Gegeven: 0

   •    Aantal posts: 0

   After-Hours Movers 8/19: HMPR, NM, BFRM, DIVX, LTD Higher; CTRN, PETM, NTAP Lower
   
   Hampton Roads Bankshares, Inc. (Nasdaq: HMPR) 12.5% HIGHER; today announced that it had withdrawn a proposed public offering of up to 32,500,000 shares of its common stock.
   
   Citi Trends, Inc. (Nasdaq: CTRN) 12.3% LOWER; reports Q2 EPS of $0.00, 5 cents lower than the analyst estimate of $0.05. Revenue for the quarter was $111.6 million, versus the consensus of $124.70 million. Same store sales fell 12.4% during the quarter.
   
   PetSmart (Nasdaq: PETM) 10.2% LOWER; reports Q2 EPS of $0.31, 2 cents better than the analyst estimate of $0.29. Revenue for the quarter was $1.31 billion, versus the consensus of $1.32 billion. Q2 comes came in up 0.8%. Sees Q3 EPS of $0.20-$0.24, versus the consensus of $0.26, with same store sales flat. Lowered its FY09 EPS guidance from $1.42-$1.52 to $1.37-$1.45.
   
   Navios Maritime Holdings Inc. (NYSE: NM) 7.6% HIGHER; reports Q2 EPS of $0.21, 10 cents better than the analyst estimate of $0.11 and compared to $0.72 in the same quarter last year. Revenue for the quarter was $142.21 million, versus the consensus of $120.29 million.
   
   BioForm Medical (Nasdaq: BFRM) 5.7% HIGHER; reports Q4 loss of $0.04, 6 cents better than the analyst estimate of ($0.10). Revenue for the quarter was $19.2 million, versus the consensus of $15.21 million. Sees FY10 sales of $64-$70 million, versus the consensus of $66.36 million.
   
   NetApp, Inc. (Nasdaq: NTAP) 4.6% LOWER; reports Q1 EPS of $0.22, ex-items, 2 cents better than the analyst estimate of $0.20. Revenue for the quarter was $838 million, versus the consensus of $828.30 million. Sees Q2 adj-gross margin of 62.5%-63%.
   
   DivX, Inc. (Nasdaq: DIVX) 3.3% HIGHER; DivX and Yahoo! (Nasdaq: YHOO) have reached a mutually agreeable settlement with respect to the parties' litigation surrounding their two-year License and Distribution Agreement entered into by the two companies in September 2007. As a result, DivX has upwardly revised GAAP earnings guidance for the third quarter by $0.29 per diluted share, or $0.17 per diluted share net of related taxes, and now expect GAAP earnings to be in the range of $0.10 to $0.12 per diluted share.
   
   Limited Brands (NYSE: LTD) 3% HIGHER; reports Q2 EPS of $0.19, ex-items, 3 cents better than the analyst estimate of $0.16. Revenue for the quarter was $2.07 billion, versus the consensus of $2.06 billion. Q2 same store sales fell 9%. Sees Q3 loss of $0.07-$0.12, which compares to the Street estimate of ($0.09). Raises its FY09 EPS guidance from $0.67-$0.87 to $0.75-$0.90.
   
   --------------------------------------------------------------------------------------------------------
   En hier nog een hele waslijst van wie met resultaten naar buiten moet komen.
   
   Before Market Opens: Earnings:
   
   1-800-flowers.com (Nasdaq: FLWS) - consensus loss $0.03
   Baldwin Technology (NYSE: BLD) - consensus EPS $0.01
   Barnes & Noble (NYSE: BKS) - consensus EPS $0.09
   Bon-Ton Stores (Nasdaq: BONT) - consensus loss $2.24
   Dick's Sporting Goods (NYSE: DKS) - consensus EPS $0.31
   GameStop (NYSE: GME) - consensus EPS $0.29
   HJ Heinz (NYSE: HNZ) - consensus EPS $0.62
   Hormel Foods (NYSE: HRL) - consensus EPS $0.52
   Kensey Nash (Nasdaq: KNSY) - consensus EPS $0.39
   LSI Industries (Nasdaq: LYTS) - consensus loss $0.03
   Ross Stores (Nasdaq: ROST) - consensus EPS $0.82
   Sears Holdings (Nasdaq: SHLD) - consensus EPS $0.35
   Stein Mart (Nasdaq: SMRT) - consensus loss $0.02
   Suntech (NYSE: STP) - consensus EPS $0.02
   Toro (NYSE: TTC) - consensus EPS $0.49
   
   Earnings:
   
   Foot Locker (NYSE: FL) - consensus EPS $0.07
   Harris Stratex (Nasdaq: HSTX) - consensus EPS $0.03
   Regis Corp. (NYSE: RGS) - consensus EPS $0.46
   Rio Tinto (NYSE: RTP)
   The Buckle (NYSE: BKE) - consensus EPS $0.52
   Children's Place (Nasdaq: PLCE) - consensus loss $0.44
   Wet Seal (Nasdaq: WTSLA) - consensus EPS $0.03
   
   After Market Closes: Earnings:
   
   Aeropostale (NYSE: ARO) - consensus EPS $0.56
   Brocade (Nasdaq: BRCD) - consensus EPS $0.11
   Gap (NYSE: GPS) - consensus EPS $0.32
   Hibbett Sports (Nasdaq: HIBB) - consensus EPS $0.10
   Intuit (Nasdaq: INTU) - consensus loss $0.12
   Jamba (Nasdaq: JMBA) - consensus EPS $0.03
   Mentor Graphics (Nasdaq: MENT) - consensus loss $0.01
   Nordson (Nasdaq: NDSN) - consensus EPS $0.50
   Pacific Sunwear (Nasdaq: PSUN) - consensus loss $0.23
   Salesforce.com (NYSE: CRM) - consensus EPS $0.15
   ScanSource (Nasdaq: SCSC) - consensus EPS $0.35
   Verigy (Nasdaq: VRGY) - consensus loss $0.30
   Zumiez (Nasdaq: ZUMZ) - consensus loss $0.13
   
   Skip
4. [verwijderd] 21 augustus 2009 01:59

   auteur info

   •    [verwijderd]

     Lid sinds: 01 jan 0001

     Laatste bezoek: 01 jan 0001

   •    Aanbevelingen

     Ontvangen: 0

     Gegeven: 0

   •    Aantal posts: 0

   After-Hours Movers 8/20: ADLR, MENT, NDSN, Higher; MDTL, ZIGO, HIBB, JMBA, HSTX Lower
   
   Medis Technologies (Nasdaq: MDTL) 16.6% LOWER; today announced that, subsequent to its notification by Nasdaq that Nasdaq considers Medis to be out of compliance with various Nasdaq requirements including the maintenance of certain levels of net worth, Medis' common stock will be delisted from the Nasdaq Global Market effective at the open of business tomorrow and is expected to be quoted on the Pink Sheets beginning at the opening of the market tomorrow. The ticker symbol will remain the same: MDTL.
   
   Adolor Corporation (NASDAQ: ADLR) 18% HIGHER; and GlaxoSmithKline (NYSE: GSK) today announced that an economic analysis of Phase 3 clinical trial data reported that the use of ENTEREG after bowel resection surgery decreased the amount of time patients spent in the hospital by one day, resulting in lower estimated hospital costs compared with placebo. The results, published in the American Journal of Health-System Pharmacy, were based on a post-hoc pharmacoeconomic analysis of pooled data consisting of 1,409 patients who participated in four randomized, double-blind, placebo-controlled, Phase 3 efficacy studies of ENTEREG conducted in North America.
   
   Mentor Graphics (Nasdaq: MENT) 11% HIGHER; reports Q2 EPS of $0.02, cents better than the analyst estimate of ($0.10). Revenue for the quarter was $182.6 million, versus the consensus of $165.77 million. Sees Q3 sales of about $183M versus $179.6 million consensus. Sees Q3 adjusted EPS of about $0.01 versus a loss of 2c.
   
   ZYGO (Nasdaq: ZIGO) 11% LOWER; reports Q4 loss of $0.33 adjusted versus the analyst estimate of ($0.17). Revenue for the quarter was $24.2 million, versus the consensus of $46.20 million. Merger termination hurt EPS by $2.48.
   
   Hibbett Sports Inc. (Nasdaq: HIBB) 9.6% LOWER; reports Q2 EPS of $0.04, 6 cents worse than the analyst estimate of $0.10. Revenue for the quarter was $123.1 million, versus the consensus of $124.99 million. Q2 comps fell 3.6%. Hibbett Sports sees FY10 comps down 4%-unchanged. Sees FY EPS of $0.85-$0.90, versus prior guidance of $1.03-$1.17 and the consensus of $1.11.
   
   Nordson (Nasdaq: NDSN) 9.2% HIGHER; reports Q3 EPS of $0.71 ex-items, 21 cents better than the analyst estimate of $0.50. Revenue for the quarter was $206 million, versus the consensus of $204.81 million. Sees Q4 revs $224M-$235 versus $224.6M consensus. Sees Q4 EPS 78c to 87c versus 57c consensus.
   
   Jamba Juice (Nasdaq: JMBA) 9.1% LOWER; reports Q2 loss of $0.10, versus the analyst estimate of $0.03. Revenue for the quarter was $83.2 million, versus the consensus of $84.15 million. Same store sales fell 13.7%.
   
   SkillSoft Corporation (Nasdaq: SKIL) 6.5% HIGHER; reports Q2 EPS of $0.17, 3 cents better than the analyst estimate of $0.14. Revenue for the quarter was $78.9 million, versus the consensus of $76.38 million. SkillSoft sees Q3 EPS of $0.12-$0.14, versus the consensus of $0.13. SkillSoft narrowed FY revenue guidance from a range of $300-$310 million to a range of $307-$310 million. SkillSoft raised FY EPS from $0.55-$0.58 to a new range of $0.59-$0.62 and the consensus of $0.58.
   
   ExpressJet Holdings (NYSE: XJT) 6% HIGHER; announced that its Board of Directors has authorized an additional $10 million for the previously announced securities repurchase program.
   
   Harris Stratex Networks, Inc. (Nasdaq: HSTX) 6.2% LOWER; reports Q4 EPS of $0.09, 6 cents better than estimates. Revenue for the fourth quarter of fiscal 2009 was $135.2 million vs. $141.66 million consensus. The Company's current revenue expectations for the first quarter of fiscal year 2010 are in the range of $120 million to $140 million. (Consensus is $152.73M)
   
   Verigy, Ltd. (Nasdaq: VRGY) 6% LOWER; reports Q2 loss of $0.24, 6 cents better than the analyst estimate of ($0.30). Revenue for the quarter was $87 million, versus the consensus of $83.33 million. Verigy, Ltd. sees a Q4 loss of $0.17-$0.25, versus the consensus of a loss of $0.18. Sees Q4 revenues of $90-$100 million, versus the consensus of $94.2 million.
   
   Brocade Communications Systems, Inc. (Nasdaq: BRCD) 4.4% LOWER; reports Q2 EPS of $0.12 adjusted, 1 cent better than the analyst estimate of $0.11. Revenue for the quarter was $493.3 million, versus the consensus of $503.67 million.
   
   The Wet Seal, Inc. (Nasdaq: WTSLA) 4.3% HIGHER; reports Q2 EPS of $0.03 versus the analyst estimate of $0.03. Revenue for the quarter was $136.4 million, versus the consensus of $136.06 million. Comps were down 10.6%. Sees Q3 EPS 2c to 5c versus 6c consensus.
   
   Pacific Sunwear of California, Inc. (Nasdaq: PSUN) 2.4% LOWER; reports Q2 loss of $0.22, 1 cents better than the analyst estimate of ($0.23). Revenue for the quarter was $243 million, versus the consensus of $239.67 million. Q2 comps down 24%. Pacific Sunwear sees a Q3 loss of $0.16-$0.23, versus the consensus of a $0.09 loss. Pacific Sunwear sees Q3 comps down high teens-low twenties.
   
   ADLR 1.57
   After Hours: 1.94 Up 0.37 (23.57%)
   
   BRCD 8.05
   After Hours: 7.49 Down -0.56 (-6.96%)
   
   HIBB 17.9
   After Hours: 16.35 Down -1.55 (8.66%)
   
   HSTX 6.39
   After Hours: 6.00 Down -0.39 (-6.10%)
   
   JMBA 1.25
   After Hours: 1.12 Down -0.13 (-10.40%)
   
   MDTL 0.34
   After Hours: 0.28 Down -0.06 (-17.65%)
   
   MENT 7.92
   After Hours: 8.80 Up 0.88 (11.11%)
   
   PSUN 3.99
   After Hours: 3.70 Down -0.29 (-7.27%)
   
   SKIL 8.92
   After Hours: 9.51 Up 0.59 (6.61%)
   
   VRGY 12.23
   After Hours: 11.30 Down 0.93 (7.60%)
   
   WTSLA 3.32
   After Hours: 3.11 Down 0.21 (6.33%)
   
   XJT 1.59
   After Hours: 1.70 Up 0.11 (6.92%)
   
   ZIGO 6.39
   After Hours: 5.69 Down -0.70(-10.95%)
   
   finance.yahoo.com/q?s=ADLR,BRCD,CRM,GSK,HIBB,HSTX,INTU,JMBA,MDTL,MENT,NDSN,PSUN,SCSC,SKIL,VRGY,WTSLA,XJT,ZIGO&d=s
   
   Gr, Skip
5. [verwijderd] 21 augustus 2009 03:09

   auteur info

   •    [verwijderd]

     Lid sinds: 01 jan 0001

     Laatste bezoek: 01 jan 0001

   •    Aanbevelingen

     Ontvangen: 0

     Gegeven: 0

   •    Aantal posts: 0

   Stocks to Watch - 8/21/09 - Stock Market Ideas
   
   American Intl Group, Inc. (AIG) - AIG exploded higher again on Thursday, this time, with heavy volume. Resistance is currently located at $35 as well as $38.60 from May 2009. I like trading AIG as long as it remains over $30. I'd be a buyer of pullbacks below $27 if the stock ends up selling off.
   
   SIRIUS XM Radio Inc. (SIRI) - SIRI continue the break out which started last week. Resistance is located at $0.75 and then $1.00. If SIRI can get back above $11, look for a huge buying surge to occur. Check out my SIRI Technical Analysis
   
   Citigroup Inc (C:NYSE) - Back over the 200 day moving average ( currently at $4.26 ). Citigroup is now hitting resistance in the $4.40's. I am long the stock and will now be an aggressive buyer on pullbacks to the 200 day moving average. I will also be a buyer when Citigroup can break above $4.48. Personal Target - $5-$5.50. Check out my recent Citigroup Technical Analysis
   
   Direxion Daily Financial Bear 3X Shares (FAZ)
   Daily Finan. Bull 3X Shs(ETF)(FAS) - FAS is back trading over $70...if you are trading these two stocks, FAS is in charge again. As soon as FAS breaks down through $70, I will be trading FAZ. FAS has resistance at $75 and $79.36. If the market has another leg higher FAS could be headed to $100. These are trading stocks....always have to take profits when you get them.
   
   Bank of America Corp ( BAC ) - Bank of America Corporation is having a decent day but it seems that all the attention is on Citigroup today. BAC will get moving again if it breaks $17.93. If the stock does get a major pullback, I plan to buy aggressively
   
   Freddie Mac (FRE) - Love FRE as long as it remains over $1.50, the next major resistance levels I will be watching out for are $1.61 & $1.69. Would be cautious below $1.50 however.
   
   Fannie Mae (FNM) - Resistance $1.12 & $1.18, then you could really see FNM move. I only like this stock above $1.00.
   
   Cell Therapeutics, Inc. (CTIC) - Investors are expecting an application decision out of the FDA on Monday, August 24, 2009. Two major resistance levels I am watching are located at $1.85 and $1.90.
   
   Hemispherx Biopharma, Inc. (HEB) - Still looking to buy on a break above $2.....should see a nice pop when this happens!
   
   Mvg,Skip
   
6. [verwijderd] 21 augustus 2009 11:02

   auteur info

   •    [verwijderd]

     Lid sinds: 01 jan 0001

     Laatste bezoek: 01 jan 0001

   •    Aanbevelingen

     Ontvangen: 0

     Gegeven: 0

   •    Aantal posts: 0

   Bedankt Skippy,
   Het schijnt dat EKO mn. zich richt op bacteriele filters (maskers) schijnen een smanewerking aangegaan met Microban, veel potentie.
   PharmaGap gaat door naar een 2e fase 60 Cell-line 5 doses fase. Resultaten moeten ieder moment naar buiten komen van het Nat.Cancer Institute. Uitbraak??
   
   gr
   R
7. Cézan 23 augustus 2009 11:17

   auteur info

   •    Cézan

     Lid sinds: 07 apr 2001

     Laatste bezoek: 20 jun 2024

   •    Aanbevelingen

     Ontvangen: 1069

     Gegeven: 1096

   •    Aantal posts: 12.286

   Skip, hulde voor de berg info die je hier plaatst.
   Mijn oog viel hierop en heb het op mijn watch bij GF gezet.
   
   XJT
   www.google.com/finance?q=NYSE:XJT
   
   Czn.
8. [verwijderd] 24 augustus 2009 11:37

   auteur info

   •    [verwijderd]

     Lid sinds: 01 jan 0001

     Laatste bezoek: 01 jan 0001

   •    Aanbevelingen

     Ontvangen: 0

     Gegeven: 0

   •    Aantal posts: 0

   Stocks to Watch - 8/24/09 - Stock Market Ideas
   
   Citigroup Inc (C:NYSE) - Citigroup was on fire Friday after breaking up through $4.48 and closing over the 200 day moving average on Thursday. Resistance is located at the high on Friday of $4.86 and $5.00. I will be buying any pullbacks to $4.48 and the 200 day moving average.
   
   American Intl Group, Inc. (AIG) - AIG failed at the $35 resistance level again Friday. I will be buying pullbacks below $30 with at $29.99. AIG stock should see a pop when $35 is finally broken to the upside.
   
   SIRIUS XM Radio Inc. (SIRI) - Waiting for SIRI stock to close above $0.75. I would like to buy any pullbacks into the low $0.60's. C
   
   Freddie Mac (FRE) - Continues to surge higher but failed to close above $1.89 resistance. Love pullbacks to $1.50 for a buy
   
   Fannie Mae (FNM) - Resistance $1.32 & $1.43 - Love pullbacks to $1. Friday was the highest close of 2009 so far....very bullish
   
   Cell Therapeutics, Inc. (CTIC) - Fast Track FDA decision on 8/24/09 - Check out my CTIC Technical Analysis
   
   Direxion Daily Financial Bear 3X Shares (FAZ)
   Daily Finan. Bull 3X Shs(ETF)(FAS) - FAS is surging once again with the overall stock market. Resistance continues to be located at $79.36 while support is Friday's low of $74.26. I will only be buying FAZ if FAS breaks down below $70.
   
   
   
   Bank of America Corp ( BAC ) - Bank of America Corporation is now trading solidly in the $17's. Watching for a close above $17.93
   
   Ambac Financial Group, Inc. (ABK) - Another stock worth watching is ABK. Resistance is located at $1.22 as well as $1.64. ABK closed over all three major moving averages on Friday and has support at $1.10 & $1.00.
   
   Las Vegas Sands Corp. (LVS) - LVS stock continues it's journey toward the November 2008 high of $16.81. All pullbacks to the 10 day moving average have been bought heavily and offer a nice support level.
   
   Hemispherx Biopharma, Inc. (HEB) - For a trade, I will be buying HEB when it breaks up through $1.96 and adding more when it breaks above $2. This should provide a solid gain in my opinion.
   
   Other Biotech stocks to watch closely: This little biotechs can pop at any time and are on my radar. XOMA Ltd. (XOMA) - ACADIA Pharmaceuticals, Inc. (ACAD) - Ariad Pharmaceuticals Inc. (ARIA) - Novavax, Inc. (NVAX) - Angiotech Pharmaceuticals, Inc. (ANPI) - Inovio Biomedical Corporation (INO) - Jazz Pharmaceuticals, Inc. (JAZZ) - Helicos BioSciences Corporation (HLCS)
   
   Gr, Skip
9. [verwijderd] 28 augustus 2009 00:31

   auteur info

   •    [verwijderd]

     Lid sinds: 01 jan 0001

     Laatste bezoek: 01 jan 0001

   •    Aanbevelingen

     Ontvangen: 0

     Gegeven: 0

   •    Aantal posts: 0

   8/27: OVTI, ARUN, DLLR, MRVL, LAVA, MCRS,JCG Higher; NZ, BEBE, NOVL Lower
   
   OmniVision Technologies, Inc. (Nasdaq: OVTI) 14.7% HIGHER; reports a Q1 loss of $0.08, 3 cents better than estimates. Revenues for the first quarter of fiscal 2010 were $105.6 million vs. $99.13 million consensus. Based on current trends, the Company expects fiscal second quarter 2010 revenues will be in the range of $155 million to $170 million vs. consensus of $111.81M. The Company expects its non-GAAP net income per share attributable to OmniVision Technologies, Inc. common stockholders will be between $0.10 and $0.20 per diluted share. (Consensus is a loss of $0.04)
   
   Aruba Networks, Inc. (Nasdaq: ARUN) 10.5% HIGHER; reports Q4 EPS of $0.03, ex-items, 1 cent better than the analyst estimate of $0.02. Revenue for the quarter was $53.3 million, versus the consensus of $49.45 million.
   
   Dollar Financial Corp. (Nasdaq: DLLR) 8.6% HIGHER; reports Q4 EPS of $0.39, ex-items, 6 cents better than the analyst estimate of $0.33. Sees FY10 adj-EP Sof $1.90-$2.10, versus the consensus of $1.79.
   
   Netezza Corporation (NYSE: NZ) 7.2% LOWER; reports Q2 EPS of $0.04, 3 cents better than estimates. Revenues were $43.9 million vs. $46.50 million consensus.
   
   Marvell Technology Group Ltd. (Nasdaq: MRVL) 6% HIGHER; reports Q2 adj-EPS of $0.18, 4 cents better than the analyst estimate of $0.14. Revenue for the quarter was $640.6 million, versus the consensus of $619.83 million.
   
   Magma Design Automation Inc. (Nasdaq: LAVA) 5% HIGHER; reports Q1 EPS of $0.03, 2 cents better than estimates. Revenues were $28.84 million vs. $28.60 million consensus. For Magma's fiscal 2010 second quarter, ending Nov. 1, 2009, the company expects total revenue in the range of $28.5 million to $29.0 million. (Consensus is $30.40M) Non-GAAP earnings per share (EPS) are expected to be in the range of $0.01 to $0.02. (Consensus is $0.01)
   
   Bebe Stores (Nasdaq: BEBE) 4.9% LOWER; reports Q4 EPS of $0.00, 1 cent lower than the analyst estimate of $0.01. Revenue for the quarter was $130.2 million, versus the consensus of $129.42 million. Same store sales fell 29.6%. Sees Q1 ex-write-off breakeven to a loss of $0.05. The Street is expecting Q1 EPS of $0.04.
   
   MICROS System (Nasdaq: MCRS) 3.5% HIGHER; reports Q4 adj-EPS of $0.36, 4 cents better than the analyst estimate of $0.32. Revenue for the quarter was $224.2 million, versus the consensus of $214.60 million. Approves a 2 million share buyback.
   
   J. Crew Group, Inc. (NYSE: JCG) 2.9% HIGHER; reports Q2 EPS of $0.29, 14 cents better than the analyst estimate of $0.15. Revenue for the quarter was $357.6 million, versus the consensus of $346.86 million. Q2 gross margin increased to 41.2%. Sees Q3 EPS of $0.30-$0.33, versus the consensus of $0.30.
   
   Novell Inc. (Nasdaq: NOVL) 2.3% LOWER; reports Q3 EPS of $0.07, ex-items, in-line with the analyst estimate of $0.07. Revenue for the quarter was $216 million, versus the consensus of $216.64 million.
   
   finance.yahoo.com/q?s=OVTI,ARUN,DLLR,MRVL,LAVA,MCRS,JCG,NZ,BEBE,NOVL&d=s
   
   ------------------------------------------------------------------------------------------------------------------------------------------------------------
   
   Stocks to Watch - 8/28/09 - Stock Market Ideas
   
   American Intl Group, Inc. (AIG) - AIG hit resistance of $50 Thursday and began to fall after a guest came on CNBC and said the stock could go to $100 and beyond. Jim Cramer then said based on the reverse split, AIG stock hasn't really even moved yet. Support is located at $46 & 44.50. A close above $50 at anytime would spark another surge. AIG will be the most active stock to daytrade over the next few days.
   
   Citigroup Inc (C:NYSE) - Citigroup finally broke $5 Thursday and ran to $5.10. A close over $5 would be huge.
   
   DryShips, Inc. (DRYS) - Huge afternoon surge in shares of Dryships, Inc. on heavy volume. The stock is now trading back over the 10 & 50 day moving averages. Resistance is located at $7 & $7.10, and then the stock should really break out. I bought this stock Thursday but will probably sell if it closes back below $6.
   
   Ambac Financial Group, Inc. (ABK) - This is another stock that could catch fire with all the financial related stocks surging. I am watching the two previous highs of $1.64 and $2.09.
   Fannie Mae (FNM) - Resistance $1.93, $2, $2.13
   
   Freddie Mac (FRE) - Resistance - $2.19, $2.35
   
   SIRIUS XM Radio Inc. (SIRI) - SIRI hit support at the 10 day moving average and bounced nicely. I continue to like pullbacks to $0.65 with a stop at $0.59. A close over $0.75 would be very bullish.
   
   Direxion Daily Financial Bear 3X Shares (FAZ)
   Daily Finan. Bull 3X Shs(ETF)(FAS) - Despite the large sell off early Thursday in the stock market, FAS continues to hold Friday's low of $74.29. If FAS breaks below $74.29 at anytime would get me to buy FAZ. This is the trade I am looking for the most.
   
   Las Vegas Sands Corp. (LVS) - Resistance = $14.93 & $16.81, LVS is holding strong in the $14's.
   
   Bank of America Corp ( BAC ) - Bank of America Corporation continues to hit resistance right below $18. I will be taking a long position on a close over $17.93 with a tight stop at $17.58. With Citi and AIG running wild, BAC can easily get back into the $20's.
   
   Immunomedics (IMMU) - Positive Lupus drug data sparked a spike in shares of IMMU stock Thursday. This is another stock to put on your watchlist for the next few weeks. A break above $7 from this point on would be bullish.
   
   Vonage Holdings Corp. (VG) - Looking to buy VG if it breaks back up above $2.25 for a quick trade.
   
   Other Stocks to Watch - August 28, 2009
   
   Compugen Ltd. (CGEN)
   EDAP TMS SA (EDAP)
   YM BioSciences Inc. (YMI)
   Oshkosh Corporation (OSK)
   Isilon Systems, Inc. (ISLN)
   RTI International Metals, Inc. (RTI)
   Gerber Scientific Inc. (GRB)
   Thomas Properties Group Inc. (TPGI)
   Casual Male Retail Group, Inc. (CMRG)
   Bon-Ton Stores Inc. (BONT)
   MBIA Inc. (MBI)
   Clean Energy Fuels Corp. (CLNE)
   Hemispherx Biopharma, Inc. (HEB)
   Cell Therapeutics, Inc. (CTIC)
   
   Penny Stocks to Watch - August 28, 2009
   
   Medialink Worldwide Inc. (MDLK)
   Fairpoint Communications, Inc. (FRP)
   Advanta Corp. (ADVNB)
   ADVANTA Corp. (ADVNA)
   Banks.com, Inc (BNX)
   Conolog Corp. (CNLG)
   Champion Enterprises Inc. (CHB)
   Lantronix Inc. (LTRX)
   Merriman Curhan Ford Group, Inc. (MERR)
   Teton Energy Corp. (TEC)
   Copernic Inc. (CNIC)
   NexMed Inc. (NEXM)
   PEACE ARCH ENT GRP B (PAE)
   Pinnacle Gas Resources, Inc. (PINN)
   Glu Mobile, Inc. (GLUU)
   Telkonet Inc. (TKO)
   Ediets.com Inc. (DIET)
   Triad Guaranty Inc. (TGIC)
   Corus Bankshares Inc. (CORS)
   Commonwealth Biotechnologies Inc. (CBTE)
   Beacon Power Corporation (BCON)
   SteelCloud Inc. (SCLD)
   Asure Software, Inc. (ASUR)
   TranSwitch Corp. (TXCC)
   Zhone Technologies Inc. (ZHNE)
   
   Gr, Skip
   
10. MyOpinion 30 augustus 2009 12:11

    auteur info

    •    MyOpinion

      Lid sinds: 22 jan 2005

      Laatste bezoek: 01 feb 2025

    •    Aanbevelingen

      Ontvangen: 220

      Gegeven: 167

    •    Aantal posts: 1.480

    NA mijn eerdere succestip IsoRay ( ik was de eerste poster over dit aandeel die veel iex posters rijk gaat maken) Nu mijn tweede smash tip:
    
    Imaging Dynamics (IDL)
11. [verwijderd] 30 augustus 2009 12:41

    auteur info

    •    [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    •    Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    quote:

    IMILLIONAIR schreef:

    NA mijn eerdere succestip IsoRay ( ik was de eerste poster over dit aandeel die veel iex posters rijk gaat maken) Nu mijn tweede smash tip:
    
    Imaging Dynamics (IDL)
    

    En waar baseer je dat op,zijn deze pas een paar dagen actief,want ik kan weinig gegevens over ze vinden.
    
    5 dagen ja,en dan schommelen ze tussen de 0.06 en 0.07
    
    Ik hoor het graag.
12. [verwijderd] 10 december 2009 21:36

    auteur info

    •    [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    •    Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    die ISORAY is na 19 aug niet veel meer geworden.
    dus weinig rijk voor jou tipvolgers!!
    imaging dynamics daarentegen heeft het binnen een maand toch leuk gedaan, maar is niet doorgestegen, is nu weer terug bij af.
13. [verwijderd] 13 juli 2010 23:58

    auteur info

    •    [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    •    Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    YRC Worldwide Inc. (NASDAQ: YRCW) - Shares continue the upward moment as investors are pouring into YRCW after the company yesterday stated news of the positive outlook of earnings. Shares reached an intraday high of $.27. Stay tune for another day of continuous coverage.
    
    Evergreen Energy Inc. (NYSE: EEE) - Shares exploded this morning when the company announced a continued equity joint venture with a Chinese counterpart to advanace the development of a K-Fuel facility. Shares reached an intraday high of $.14 or up roughly 70%. Stay tune to see if EEE continues the upward momentum.
    
    
    VIVUS, Inc. (NASDAQ: VVUS) - Shares are moving higher today as the FDA stated that the company's obesity drug appears to help people shed pounds, however some health problems are still a concern. VVUS faces FDA panel this week and if majority vote to approve the drug, shares look to move higher. Stay tune to what the FDA panel of advisors decide.
    
    
    Stereotaxis, Inc. (NASDAQ: STXS) - Shares are on a bullish outbreak as the company stated a strong increase in new capital orders in the second quarter. STXS reached an intraday high of $4.23. Will STXS continue the upward move or was this was one hit wonder? Stay tune.
    
    
    Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX) - Shares have been on a downward spiral this year and recently made a bullish bounce back. Today, shares headed lower as SOMX hit major points of resistance. Will SOMX bounce back on the bull track? SOMX reached an intraday day low of $3.07. Stay tune.
    
    
    MBIA Inc. (NYSE: MBI) - Shares reached an intraday high of $7.17 today on larger than normal volume. Will the uptrend continue or will MBI shorts come calling? Stay tune.
    
    Skip